List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #27,951 to #28,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. INSYNC → Multisite Pacing As A Supplemental Treatment Of Congestive Heart Failure: The Medtronic Inc. Insync Study
  2. INTACT → Iressa Non–Small Cell Lung Cancer Trial Assessing Combination Treatment
  3. INTAMI → Integrilin In Acute Myocardial Infarction
  4. INTERACT → Integrilin And Enoxaparin Randomized Assessment Of Acute Coronary Syndrome Treatment
  5. INTERCEPT → Incomplete Infarction Trial Of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (Diltiazem)
  6. INTERHEART → A Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects
  7. INTRACORONARY MEDICATIONS → Intracoronary pharmacotherapy
  8. INTRATONSILLAR ABSCESS → Peritonsillar abscess
  9. INTRINSIC RV → Inhibition Of Unnecessary Rv Pacing With Av Search Hysteresis In Icds
  10. INTRO-AMI → Integrilin And Reduced Dose Of Thrombolytic In Acute Myocardial Infarction
  11. INTUNIV adverse reactions → Guanfacine#Adverse Reactions
  12. INTUNIV clinical pharmacology → Guanfacine#Pharmacology
  13. INTUNIV clinical studies → Guanfacine#Clinical Studies
  14. INTUNIV contraindications → Guanfacine#Contraindications
  15. INTUNIV description → Guanfacine#Structure
  16. INTUNIV dosage and administration → Guanfacine#Adult Indications and Dosage
  17. INTUNIV dosage forms and strengths → Guanfacine#How Supplied
  18. INTUNIV drug interactions → Guanfacine#Drug Interactions
  19. INTUNIV how supplied storage and handling → Guanfacine#How Supplied
  20. INTUNIV indications and usage → Guanfacine#Adult Indications and Dosage
  21. INTUNIV labels and packages → Guanfacine#Package and Label Display Panel
  22. INTUNIV nonclinical toxicology → Guanfacine#Nonclinical Toxicology
  23. INTUNIV overdosage → Guanfacine#Overdosage
  24. INTUNIV use in specific populations → Guanfacine#Use in Specific Populations
  25. INTUNIV warnings and precautions → Guanfacine#Warnings
  26. INTrEPID → Investigation Of Non–Transplant-Eligible Patients Who Are Inotrope Dependent See
  27. INVEGA → Paliperidone
  28. INVEST → International Verapamil-Trandolapril Study
  29. IONDT → Ischemic Optic Neuropathy Decompression Trial
  30. IOP → Intraocular pressure
  31. IOPTH → Hyperparathyroidism other diagnostic studies#Other Diagnostic Studies
  32. IORT → Intraoperative radiation therapy
  33. IOSCA → ATXN8OS
  34. IO access → Intraosseous infusion
  35. IP → Incontinentia pigmenti
  36. IP3 → Inositol triphosphate
  37. IP6 → Phytic acid
  38. IPEX → IPEX (syndrome)
  39. IPF → Idiopathic pulmonary fibrosis
  40. IPH → Pulmonary hypertension
  41. IPOB → KPNB1
  42. IPSP → Inhibitory postsynaptic potential
  43. IPST → Intraprocedural stent thrombosis
  44. IPTE → Intraprocedural thrombotic events
  45. IRA → Infarct related artery
  46. IRAS → Insulin Resistance Atherosclerosis Study
  47. IRS-1 → IRS1
  48. IR spectroscopy → Infrared spectroscopy
  49. IR spectrum → Electromagnetic spectrum
  50. ISA → Intrinsic sympathomimetic activity

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"